SBC Medical Group
SBC | NASDAQ
$5.14
+$0.39 (+8.21%)
At close: Sep 21, 2026, 4:00 PM ET
$5.24
+$0.10 (+1.95%)
Pre-market:
Sep 22, 2026, 4:43 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 163.77M | 125.04M | 103.02M | 51.74M |
Short-Term Investments | 319.19K | n/a | n/a | 1.91M |
Long-Term Investments | 58.02M | 20.87M | 20.66M | 916.03K |
Other Long-Term Assets | 7.66M | 30.72M | 29.41M | 73.7M |
Receivables | 53.1M | 48.19M | 53.13M | 43.65M |
Inventory | 2.79M | 1.49M | 3.09M | 1.35M |
Other Current Assets | 127.18K | 25.54K | 162.12K | 37.23K |
Total Current Assets | 231.22M | 184.45M | 165.91M | 112.95M |
Property-Plant & Equipment | 16.36M | 14.04M | 19.5M | 21.51M |
Goodwill & Intangibles | 63.17M | 6.2M | 23.33M | 11.14M |
Total Long-Term Assets | 149.22M | 81.63M | 92.9M | 112.53M |
Total Assets | 380.45M | 266.08M | 258.81M | 225.48M |
Account Payables | 17.64M | 14.53M | 26.53M | 15.32M |
Deferred Revenue | 6.77M | 12.56M | 25.13M | 30.44M |
Short-Term Debt | 9.1M | 123.08K | 3.53M | 4.76M |
Other Current Liabilities | 5.43M | 227.89K | 832.52K | 25.2M |
Total Current Liabilities | 61.12M | 61.19M | 92.45M | 101.25M |
Long-Term Debt | 33.73M | 6.51M | 13.01M | 5.53M |
Other Long-Term Liabilities | 1.66M | 1.19M | 1.07M | 1.15M |
Total Long-Term Liabilities | 56.02M | 9.87M | 22.54M | 16.38M |
Total Liabilities | 117.14M | 71.06M | 115M | 117.63M |
Total Debt | 51.64M | 12.21M | 22.87M | 16.13M |
Book Value | 263.3M | 195.02M | 143.81M | 107.85M |
Book Value Per Share | 2.56 | 2.02 | 1.53 | 7.16 |
Common Stock | 10.39K | 10.3K | 9.42K | n/a |
Retained Earnings | 240.45M | 189.46M | 142.85M | 103.48M |
Comprehensive Income | -57.29M | -54.18M | -37.58M | -24.85M |
Shareholders Equity | 248.28M | 195.11M | 142.16M | 105.25M |
Total Investments | 58.34M | 20.87M | 20.66M | 2.82M |
Add to Watchlist
Select watchlists to add or remove SBC